| Completed | Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study NCT02324595 | Catholic University of the Sacred Heart | Phase 2 |
| Completed | Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients NCT01905163 | Centre Jean Perrin | Phase 2 |
| Completed | Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer NCT01670799 | New Mexico Cancer Research Alliance | EARLY_Phase 1 |
| Terminated | Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer NCT01137071 | Recepta Biopharma | Phase 2 |
| Completed | A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer NCT01281514 | Fox Chase Cancer Center | Phase 1 |
| Completed | Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Canc NCT01166737 | AGO Study Group | N/A |
| Completed | Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer NCT00993655 | Canadian Cancer Trials Group | Phase 2 |
| Terminated | Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor NCT01096381 | Vanderbilt-Ingram Cancer Center | — |
| Unknown | Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, NCT01074398 | Gynecologic Oncology Group | — |
| Terminated | Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Can NCT00903630 | Masonic Cancer Center, University of Minnesota | Phase 1 / Phase 2 |
| Completed | Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Canc NCT00825201 | City of Hope Medical Center | Phase 1 |
| Completed | Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers NCT00803569 | Ludwig Institute for Cancer Research | Phase 1 |
| Terminated | Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Periton NCT00652899 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies NCT00625092 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer NCT00702299 | University of Arizona | Phase 1 |
| Terminated | Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Canc NCT00748527 | Cancer Research UK | Phase 2 |
| Terminated | Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or NCT00536523 | University of Minnesota | — |
| Completed | Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That NCT00436644 | Mayo Clinic | Phase 2 |
| Completed | Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ova NCT00466960 | University of Washington | Phase 2 |
| Withdrawn | Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Prima NCT00369954 | Gynecologic Oncology Group | Phase 2 |
| Terminated | Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallop NCT00354601 | Wake Forest University Health Sciences | Phase 2 |
| Terminated | Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or NCT00331422 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Prima NCT00217568 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carc NCT00357448 | University of Washington | Phase 1 |
| Completed | Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer NCT00112957 | Ludwig Institute for Cancer Research | Phase 2 |
| Completed | Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or P NCT00030706 | Montefiore Medical Center | Phase 2 |
| Completed | Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peri NCT00101257 | Fred Hutchinson Cancer Center | Phase 1 |
| Terminated | Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer NCT00287859 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian NCT00217529 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer NCT00245050 | Case Comprehensive Cancer Center | Phase 3 |
| Completed | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer NCT00287885 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Ca NCT00227721 | Robert Morris | Phase 2 |
| Completed | Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelia NCT00538031 | City of Hope Medical Center | Phase 2 |
| Terminated | Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma NCT00653328 | Vanderbilt-Ingram Cancer Center | Phase 2 |
| Completed | S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer NCT00043082 | SWOG Cancer Research Network | Phase 3 |
| Terminated | PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopi NCT00085384 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primar NCT00217555 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or NCT00897806 | M.D. Anderson Cancer Center | — |
| Completed | Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT00030446 | NCIC Clinical Trials Group | Phase 2 |
| Completed | Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube C NCT00028743 | NCIC Clinical Trials Group | Phase 3 |
| Completed | S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer NCT00008138 | SWOG Cancer Research Network | Phase 2 |
| Completed | Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, S NCT00550784 | City of Hope Medical Center | Phase 1 |
| Completed | Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer NCT00010179 | NCIC Clinical Trials Group | Phase 2 |
| Completed | Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, NCT00006391 | NYU Langone Health | Phase 1 |
| Completed | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery NCT00004895 | Northwestern University | Phase 2 |
| Completed | S9912 Combination Chemo in Stage III Ovarian Cancer, NCT00003896 | SWOG Cancer Research Network | Phase 2 |
| Completed | Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer NCT00004081 | Beth Israel Deaconess Medical Center | Phase 2 |
| Completed | Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal C NCT00003450 | University of Texas Southwestern Medical Center | Phase 1 |
| Completed | Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Trea NCT00652691 | Mayo Clinic | Phase 1 |
| Completed | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stag NCT00003944 | Fox Chase Cancer Center | Phase 2 |
| Completed | S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in R NCT00003120 | SWOG Cancer Research Network | Phase 3 |
| Completed | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Can NCT00005049 | NYU Langone Health | Phase 2 |